现金流量表（National Health Investors Inc）
| 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|
| 起始日期 | 2023-01-01 | 2023-01-01 | 2023-01-01 | 2023-01-01 | 2022-01-01 | 2022-01-01 | 2022-01-01 | 2022-01-01 |
| 截止日期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 报表年结日 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 |
| 原始币种 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 经营活动产生的现金流量： | ||||||||
| 净利润(元) | 134,381,000.00 | 102,662,000.00 | 73,630,000.00 | 34,183,000.00 | 65,501,000.00 | 63,941,000.00 | 29,712,000.00 | 8,246,000.00 |
| 折旧及摊销(元) | 76,767,000.00 | 54,337,000.00 | 36,188,000.00 | 17,768,000.00 | 81,846,000.00 | 60,252,000.00 | 42,724,000.00 | 18,404,000.00 |
| 基于股票的补偿费(元) | 4,605,000.00 | 3,740,000.00 | 2,874,000.00 | 2,105,000.00 | 8,613,000.00 | 7,576,000.00 | 6,511,000.00 | 5,083,000.00 |
| 减值及拨备(元) | - | 3,392,000.00 | 2,082,000.00 | 1,048,000.00 | - | 3,216,000.00 | - | - |
| 资产处置损益(元) | -14,721,000.00 | -13,500,000.00 | -12,763,000.00 | -1,397,000.00 | -28,342,000.00 | -28,342,000.00 | -13,502,000.00 | -2,981,000.00 |
| 投资损益(元) | -1,229,000.00 | -1,229,000.00 | -711,000.00 | -376,000.00 | -4,163,000.00 | -3,105,000.00 | - | - |
| 权益性投资损益(元) | -555,000.00 | - | - | - | -569,000.00 | -569,000.00 | -569,000.00 | -297,000.00 |
| 经营业务调整其他项目(元) | -18,085,000.00 | -16,784,000.00 | -17,704,000.00 | -15,015,000.00 | 65,151,000.00 | 42,070,000.00 | 33,488,000.00 | 14,969,000.00 |
| 待摊费用及其他资产(元) | - | - | - | - | - | - | -2,563,000.00 | -107,000.00 |
| 应付账款及票据增加(减少)(元) | 5,929,000.00 | 1,317,000.00 | 776,000.00 | -3,277,000.00 | 425,000.00 | -2,555,000.00 | -276,000.00 | -4,252,000.00 |
| 递延收入(元) | 101,000.00 | -262,000.00 | -196,000.00 | -219,000.00 | 412,000.00 | 712,000.00 | -77,000.00 | -385,000.00 |
| 经营业务其他项目(元) | -2,743,000.00 | -2,426,000.00 | -2,632,000.00 | -3,772,000.00 | -3,534,000.00 | -4,213,000.00 | - | - |
| 经营活动产生的现金流量净额(元) | 184,450,000.00 | 131,247,000.00 | 81,544,000.00 | 31,048,000.00 | 185,340,000.00 | 138,983,000.00 | 95,448,000.00 | 38,680,000.00 |
| 投资活动产生的现金流量： | ||||||||
| 购买固定资产支付的现金(元) | -49,556,000.00 | -46,135,000.00 | -42,458,000.00 | -40,214,000.00 | -10,993,000.00 | -9,536,000.00 | -7,746,000.00 | -165,000.00 |
| 处置固定资产收到的现金(元) | 57,031,000.00 | 51,542,000.00 | 48,619,000.00 | 10,201,000.00 | 168,958,000.00 | 168,957,000.00 | 108,893,000.00 | 13,170,000.00 |
| 投资支付现金(元) | -35,625,000.00 | -33,104,000.00 | -12,174,000.00 | -7,219,000.00 | -79,801,000.00 | -30,820,000.00 | - | - |
| 投资业务其他项目(元) | 16,520,000.00 | 13,731,000.00 | 11,993,000.00 | 9,711,000.00 | 119,781,000.00 | 118,542,000.00 | 91,076,000.00 | -15,065,000.00 |
| 投资活动产生的现金流量净额(元) | -11,630,000.00 | -13,966,000.00 | 5,980,000.00 | -27,521,000.00 | 197,945,000.00 | 247,143,000.00 | 192,223,000.00 | -2,060,000.00 |
| 融资活动产生的现金流量： | ||||||||
| 新增借款(元) | - | - | - | - | - | -125,290,000.00 | - | - |
| 偿还借款(元) | - | - | - | - | - | - | -230,192,000.00 | -75,098,000.00 |
| 回购股份(元) | - | - | - | - | -151,951,000.00 | -151,951,000.00 | -69,977,000.00 | - |
| 股息支付(元) | -157,518,000.00 | -118,173,000.00 | -78,738,000.00 | -39,413,000.00 | -162,687,000.00 | -123,478,000.00 | -82,531,000.00 | -41,266,000.00 |
| 贷款收益(元) | -12,427,000.00 | -2,304,000.00 | -11,203,000.00 | 27,897,000.00 | -93,388,000.00 | - | 95,000,000.00 | 85,000,000.00 |
| 发行费用相关(元) | -2,747,000.00 | -2,747,000.00 | -2,747,000.00 | - | -4,678,000.00 | -4,628,000.00 | -4,612,000.00 | -4,542,000.00 |
| 现金及权益增加(减少)(元) | 2,973,000.00 | 2,922,000.00 | 2,922,000.00 | 2,000,000.00 | 11,738,000.00 | 11,738,000.00 | 11,216,000.00 | -271,000.00 |
| 筹资业务其他项目(元) | - | - | - | - | -288,000.00 | -288,000.00 | - | - |
| 融资活动产生的现金流量净额(元) | -169,719,000.00 | -120,302,000.00 | -89,766,000.00 | -9,516,000.00 | -401,254,000.00 | -393,897,000.00 | -281,096,000.00 | -36,177,000.00 |
| 现金及现金等价物期初余额(元) | 21,516,000.00 | 21,516,000.00 | 21,516,000.00 | 21,516,000.00 | 39,485,000.00 | 39,485,000.00 | 39,485,000.00 | 39,485,000.00 |
| 现金及现金等价物增加(减少)额(元) | 3,101,000.00 | -3,021,000.00 | -2,242,000.00 | -5,989,000.00 | -17,969,000.00 | -7,771,000.00 | 6,575,000.00 | 443,000.00 |
| 现金及现金等价物期末余额(元) | 24,617,000.00 | 18,495,000.00 | 19,274,000.00 | 15,527,000.00 | 21,516,000.00 | 31,714,000.00 | 46,060,000.00 | 39,928,000.00 |
| 利息支付(元) | - | - | 25,971,000.00 | 15,878,000.00 | 42,659,000.00 | 33,927,000.00 | - | - |
| 补充资料其他项目(元) | - | - | 15,493,000.00 | 14,585,000.00 | 24,882,000.00 | 11,038,000.00 | - | - |
| 公告日期 | 2024-02-20 | 2023-11-07 | 2023-08-08 | 2023-05-09 | 2023-02-21 | 2022-11-08 | 2022-08-08 | 2022-05-09 |
| 会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 |
| 审计意见 | ||||||||
| 核数师 |